市場調查報告書

質子泵抑製劑(PPI)市場(2020-2026)

Proton Pump Inhibitors (PPI) Market 2020-2026

出版商 Orion Market Research Pvt Ltd 商品編碼 949612
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
質子泵抑製劑(PPI)市場(2020-2026) Proton Pump Inhibitors (PPI) Market 2020-2026
出版日期: 2020年06月18日內容資訊: 英文
簡介

在預測期內,估計全球質子泵抑製劑市場將顯著增長。市場增長的主要驅動力包括消化問題,因為果汁,食物和其他酸性食物向食道遷移。 GERD(胃食管反流病)影響各個年齡段的人,哮喘患者罹患GERD的風險增加。此外,越來越多的消化性潰瘍,胃酸問題以及對新的輸送系統的需求不斷增長,這推動了市場的增長。

全球質子泵抑製劑市場按類型和藥物類型細分。按類型劃分,市場可分為埃索美拉唑,奧美拉唑,右蘭索拉唑,pan托拉唑,雷貝拉唑,蘭索拉唑等。根據藥品類型,市場分為非處方藥(OTC)和處方藥。由於埃索美拉唑藥物的消費量增加,輝瑞已在法國,德國和意大利等大多數歐洲國家推薦將Nexium用作OTC產品。從地理上講,全球質子泵抑製劑市場分為北美,歐洲,亞太地區和世界其他地區。由於消化問題的增加和新產品的持續生產,市場正在加速發展。

提供PPI的主要公司包括AstraZeneca PLC,武田製藥有限公司,輝瑞公司,拜耳公司,揚森製藥公司(強生服務公司的一部分),Aurobindo。藥業有限公司,衛材有限公司,寶潔公司和賽諾菲公司。這些參與者採用各種策略來保持市場競爭力並獲得市場份額。

本報告調查了全球質子泵抑製劑(PPI)市場,市場概況,市場增長因素和抑制因素分析,市場規模趨勢以及按類型,藥物類型和地區以及競爭情況做出的預測。它提供有關情況,主要公司的概況,市場機會等的系統信息。

內容

第1章報告概述

第2章市場概述和見解

  • 調查範圍
  • 分析師見解和當前市場趨勢
  • 規則與規定

第3章競爭情況

  • 公司份額分析
  • 主要策略分析
  • 主要公司分析
    • 阿斯利康PLC
    • 武田藥品有限公司 輝瑞公司(li)
    • 拜耳公司
    • Janssen Pharmaceutical,Inc.(強生服務公司的一部分)

第4章市場決定因素

  • 動機
  • 抑制因子
  • 市場機會

第5章市場細分

  • 按類型
    • 埃索美拉唑
    • 奧美拉唑
    • 右蘭索拉唑
    • top托拉唑
    • 雷貝拉唑
    • 蘭索拉唑
    • 其他
  • 按藥物類型
    • 非處方藥
    • 處方

第6章區域分析

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 意大利
    • 西班牙
    • 法國
    • 其他歐洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 其他亞太地區
  • 其他地區

第7章公司簡介

  • Alkem Laboratories, Ltd.
  • AstraZeneca PLC
  • Aurobindo Pharma, Ltd.
  • Bayer AG
  • Cadila Healthcare, Ltd.
  • Chongqing LUMMY Pharmaceutical Co., Ltd.
  • Eisai Co., Ltd.
  • GlaxoSmithKline PLC
  • Glenmark Pharmaceuticals, Inc.
  • Janssen Pharmaceutical, Inc. (A Part ofJohnson & Johnson Service Inc.)
  • Lannett Company, Inc.
  • Novartis AG
  • Pfizer, Inc.
  • Procter & Gamble Co.
  • Sanofi S.A.
  • Sun Pharmaceutical Industries, Ltd.
  • Takeda Pharmaceutical Co. Ltd.
  • Teva Pharmaceuticals Industries, Ltd.
目錄
Product Code: OMR2021931

Global Proton Pump Inhibitors (PPI) Market Size, Share & Trends Analysis Report, by Type (Esomeprazole, Omeprazole, Pantoprazole, Dexlansoprazole, Rabeprazole, Lansoprazole and other), by Administration (Over the Counter and Prescription) and Forecast Period, 2020-2026

The global proton pump inhibitors market is estimated to grow significantly during the forecast period. The major factors encouraging market growth include the digestion problem occurs when acidic intakes such as juices, food and converts into the esophagus. GERD affects all age group people, where people with asthma havea higher risk of developing GERD. Moreover, the increase in the number of peptic ulcers, gastric acid problems and rising demand fornovel delivery systems accelerating the market growth.

The global proton pump inhibitors market is segmented based on type and administration. Based on type, the market is classified intoesomeprazole, omeprazole, dexlansoprazole,pantoprazole, rabeprazole, lansoprazole, and other. Based on administration, the market is classified into OTC and prescription. Pfizer recommended Nexium as an OTC product in most of the European countries such as France, Germany, and Italy due to increase in the consumption of esomeprazole drug.Geographically, the global Proton Pump Inhibitors market is segmented into North America, Europe, Asia-Pacific, and Rest of the World.Due to the increase in the number of gastrointestinal problems andthe continuous production of new product is accelerating the market.

The major companies providing PPI includeAstraZeneca PLC, Takeda Pharmaceuticals Co. Ltd., Pfizer, Inc., Bayer AG, Janssen Pharmaceutical, Inc. (A Part of Johnson & Johnson Service Inc.), Aurobindo Pharma, Ltd., Eisai Co., Ltd., Procter & Gamble Co., and Sanofi S.A. These players adopt various strategies in order to stay competitive in the market and expand their market share.

Research Methodology

The market study of the global PPI market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders and industry experts. Primary research brings authenticity toour reports.

Secondary Sources Include:

  • Financial reports of companies involved in the market.
  • Authentic public databases
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.

The report provides an in-depth analysis on market size, intended quality of the service preferred by consumers. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation:

  • Global Proton Pump InhibitorsMarket Research and Analysisby Type
  • Global Proton Pump InhibitorsMarket Research and Analysisby Administration

The Report Covers:

  • Comprehensive research methodologies of the global proton pump inhibitorsmarket.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global proton pump inhibitors market.
  • Insights about market determinants which are stimulating the global proton pump inhibitorsmarket.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion
  • 2.3. Rules & Regulations

3. Competitive Landscape

  • 3.1. Company Share Analysis
  • 3.2. Key Strategy Analysis
  • 3.3. Key Company Analysis
    • 3.3.1. AstraZeneca PLC
      • 3.3.1.1. Overview
      • 3.3.1.2. Financial Analysis
      • 3.3.1.3. SWOT Analysis
      • 3.3.1.4. Recent Developments
    • 3.3.2. Takeda Pharmaceuticals Co. Ltd.
      • 3.3.2.1. Overview
      • 3.3.2.2. Financial Analysis
      • 3.3.2.3. SWOT Analysis
      • 3.3.2.4. Recent Developments
    • 3.3.3. Pfizer, Inc.
      • 3.3.3.1. Overview
      • 3.3.3.2. Financial Analysis
      • 3.3.3.3. SWOT Analysis
      • 3.3.3.4. Recent Developments
    • 3.3.4. Bayer AG
      • 3.3.4.1. Overview
      • 3.3.4.2. Financial Analysis
      • 3.3.4.3. SWOT Analysis
      • 3.3.4.4. Recent Developments
    • 3.3.5. Janssen Pharmaceutical, Inc. (A Part of Johnson & Johnson Service Inc.)
      • 3.3.5.1. Overview
      • 3.3.5.2. Financial Analysis
      • 3.3.5.3. SWOT Analysis
      • 3.3.5.4. Recent Developments

4. Market Determinants

  • 4.1 Motivators
  • 4.2 Restraints
  • 4.3 Opportunities

5. Market Segmentation

  • 5.1. Global Proton Pump Inhibitors Market by Type
    • 5.1.1. Esomeprazole
    • 5.1.2. Omeprazole
    • 5.1.3. Dexlansoprazole
    • 5.1.4. Pantoprazole
    • 5.1.5. Rabeprazole
    • 5.1.6. Lansoprazole
    • 5.1.7. Other
  • 5.2. Global Proton Pump Inhibitors Market by Administration
    • 5.2.1. Over the Counter
    • 5.2.2. Prescription

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. Alkem Laboratories, Ltd.
  • 7.2. AstraZeneca PLC
  • 7.3. Aurobindo Pharma, Ltd.
  • 7.4. Bayer AG
  • 7.5. Cadila Healthcare, Ltd.
  • 7.6. Chongqing LUMMY Pharmaceutical Co., Ltd.
  • 7.7. Eisai Co., Ltd.
  • 7.8. GlaxoSmithKline PLC
  • 7.9. Glenmark Pharmaceuticals, Inc.
  • 7.10. Janssen Pharmaceutical, Inc. (A Part ofJohnson & Johnson Service Inc.)
  • 7.11. Lannett Company, Inc.
  • 7.12. Novartis AG
  • 7.13. Pfizer, Inc.
  • 7.14. Procter & Gamble Co.
  • 7.15. Sanofi S.A.
  • 7.16. Sun Pharmaceutical Industries, Ltd.
  • 7.17. Takeda Pharmaceutical Co. Ltd.
  • 7.18. Teva Pharmaceuticals Industries, Ltd.

LIST OF TABLES

  • 1. GLOBAL PROTON PUMP INHIBITORS MARKET RESEARCH AND ANALYSIS BY TYPE, 2019-2026 ($ MILLION)
  • 2. GLOBAL ESOMEPRAZOLEMARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 3. GLOBAL OMEPRAZOLE MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 4. GLOBAL DEXLANSOPRAZOLEMARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 5. GLOBAL PANTOPRAZOLE MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 6. GLOBAL RABEPRAZOLE MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 7. GLOBAL LANSOPRAZOLE MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 8. GLOBAL OTHER PROTON PUMP INHIBITORS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 9. GLOBAL PROTON PUMP INHIBITORS MARKET RESEARCH AND ANALYSIS BY ADMINISTRATION, 2019-2026 ($ MILLION)
  • 10. GLOBAL OVER THE COUNTER PROTON PUMP INHIBITORS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 11. GLOBAL PRESCRIPTIONPROTON PUMP INHIBITORS MARKET RESEARCH AND ANALYSIS BY REGION, 2019-2026 ($ MILLION)
  • 12. GLOBAL PROTON PUMP INHIBITORS MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2019-2026 ($ MILLION)
  • 13. NORTH AMERICAN PROTON PUMP INHIBITORS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
  • 14. NORTH AMERICAN PROTON PUMP INHIBITORS MARKET RESEARCH AND ANALYSIS BY TYPE, 2019-2026 ($ MILLION)
  • 15. NORTH AMERICAN PROTON PUMP INHIBITORS MARKET RESEARCH AND ANALYSIS BY ADMINISTRATION, 2019-2026 ($ MILLION)
  • 16. EUROPEAN PROTON PUMP INHIBITORS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
  • 17. EUROPEAN PROTON PUMP INHIBITORS MARKET RESEARCH AND ANALYSIS BY TYPE, 2019-2026 ($ MILLION)
  • 18. EUROPEAN PROTON PUMP INHIBITORS MARKET RESEARCH AND ANALYSIS BY ADMINISTRATION, 2019-2026 ($ MILLION)
  • 19. ASIA-PACIFIC PROTON PUMP INHIBITORS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
  • 20. ASIA-PACIFIC PROTON PUMP INHIBITORS MARKET RESEARCH AND ANALYSIS BY TYPE, 2019-2026 ($ MILLION)
  • 21. ASIA-PACIFIC PROTON PUMP INHIBITORS MARKET RESEARCH AND ANALYSIS BY ADMINISTRATION, 2019-2026 ($ MILLION)
  • 22. REST OF THE WORLD PROTON PUMP INHIBITORS MARKET RESEARCH AND ANALYSIS BY TYPE, 2019-2026 ($ MILLION)
  • 23. REST OF THE WORLD PROTON PUMP INHIBITORS MARKET RESEARCH AND ANALYSIS BYADMINISTRATION, 2019-2026 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL PROTON PUMP INHIBITORS MARKET SHARE BY TYPE, 2019VS 2026 (%)
  • 2. GLOBAL PROTON PUMP INHIBITORS MARKET SHARE BY ADMINISTRATION, 2019VS 2026 (%)
  • 3. GLOBAL PROTON PUMP INHIBITORS MARKET SHARE BY GEOGRAPHY, 2019VS 2026 (%)
  • 4. US PROTON PUMP INHIBITORS MARKET SIZE, 2019-2026 ($ MILLION)
  • 5. CANADA PROTON PUMP INHIBITORS MARKET SIZE, 2019-2026 ($ MILLION)
  • 6. UK PROTON PUMP INHIBITORS MARKET SIZE, 2019-2026 ($ MILLION)
  • 7. FRANCE PROTON PUMP INHIBITORS MARKET SIZE, 2019-2026 ($ MILLION)
  • 8. GERMANY PROTON PUMP INHIBITORS MARKET SIZE, 2019-2026 ($ MILLION)
  • 9. ITALY PROTON PUMP INHIBITORS MARKET SIZE, 2019-2026 ($ MILLION)
  • 10. SPAIN PROTON PUMP INHIBITORS MARKET SIZE, 2019-2026 ($ MILLION)
  • 11. ROE PROTON PUMP INHIBITORS MARKET SIZE, 2019-2026 ($ MILLION)
  • 12. INDIA PROTON PUMP INHIBITORS MARKET SIZE, 2019-2026 ($ MILLION)
  • 13. CHINA PROTON PUMP INHIBITORS MARKET SIZE, 2019-2026 ($ MILLION)
  • 14. JAPAN PROTON PUMP INHIBITORS MARKET SIZE, 2019-2026 ($ MILLION)
  • 15. REST OF ASIA-PACIFIC PROTON PUMP INHIBITORS MARKET SIZE, 2019-2026 ($ MILLION)
  • 16. REST OF THE WORLD PROTON PUMP INHIBITORS MARKET SIZE, 2019-2026 ($ MILLION)